PharVision Advisers’s Banco Santander SAN Stock Holding History

PharVision Advisers’s Portfolio SAN Stock Details SAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-13,320	Closed	-$150K	–	123
2026 Q1	$150K	Buy	+13,320	New	+$159K	1.52%	10

Other funds holding SAN

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

PharVision Advisers's SAN Position: Q2 2026 in Review

PharVision Advisers sold out of Banco Santander (SAN) in Q2 2026, closing a stake of 13,320 shares — an estimated $150K sold.

PharVision Advisers first reported a position in SAN in Q1 2026 and held it in 1 quarter. The position peaked at $150K in Q1 2026. 657 funds tracked by Wall St. Rank hold SAN as of Q2 2026.

PharVision Advisers reported no remaining Banco Santander position as of Q2 2026 after selling out during the quarter.
PharVision Advisers sold 13,320 Banco Santander shares in Q2 2026, an estimated $150K.
PharVision Advisers first reported a position in Banco Santander in Q1 2026 and held it in 1 quarter.
PharVision Advisers's Banco Santander position peaked at $150K in Q1 2026.
657 funds tracked by Wall St. Rank held Banco Santander as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.